Atlas Trials

Eikon Therapeutics

10 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Eikon Therapeutics

RecordFirmDate
A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer. (NCT07365319)Eikon Therapeutics2026-06-15
EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors (NCT07262619)Eikon Therapeutics2026-01-20
Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma. (NCT06697301)Eikon Therapeutics2025-05-22
A Phase 2 Study of EIK1001 in Combo With Pembrolizumab and Chemotherapy in Patients With Stage 4 NSCLC (NCT06246110)Eikon Therapeutics2024-02-06
A First-in-human Study of PARP1 Selective Inhibitor, IMP1734, in Participants With Advanced Solid Tumors (NCT06253130)Eikon Therapeutics2023-12-11
BDB001-201: A Clinical Study of BDB001 in Patients With PD-(L)1 Refractory Solid Tumors (NCT04819373)Eikon Therapeutics2021-08-30
Clinical Study of BDB018: Monotherapy and in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors (NCT04840394)Eikon Therapeutics2021-06-22
BDB001-102: Open Label Dose Escalation of BDB001 in Combination w Atezolizumab (NCT04196530)Eikon Therapeutics2019-11-21
BDB001-101: Clinical Study of BDB001 as a Mono-therapy or in Combination With Pembrolizumab (NCT03486301)Eikon Therapeutics2018-02-15

Track Eikon Therapeutics automatically

Every clearance here is in the API, with alerts when new ones post.